In the TCGA classification, the POLE mutated/ultramutated group of endometrial cancers was reported as a subtype of neoplasm that showed an excellent prognosis independently of other clinicopathological variables, such as high-grade tumours [69,70] and an advanced development stage [71]. The gene discussed is POLE; the disease is endometrial cancer.